A high proportion of patients tested positive for both serum and CSF GAD65‐IgG antibodies, distinguishing it from conditions such as neuromyelitis optica spectrum disorders, or anti‐NMDAR receptor encephalitis, where antibodies are typically found predominantly in either serum or CSF [13, 14]. This evidence concerns the gene GAD2 and encephalitis.